The present study demonstrated the insulin-sensitizing, glucose-regulating, anti-obesity, and anti-hyperlipidemic properties of Furocyst in women with PCOS, and the overweight and obese seemed to be most benefitted from the drug. Here, INS is linked to polycystic ovary syndrome.